Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: potential vs buyout

RE: potential vs buyout

posted on Feb 17, 2006 08:43AM
I think you got that right--it would have to be both companies. IMHO, TPL/Moore have been working on their project now for a long long time and would not consider selling. It could be that what they are working on is needed greatly in the market--I hope so and I hope that it incorporates the 336 and we will see wonderful royalties from it in the near future. Good luck, ads
Share
New Message
Please login to post a reply